- Home
- TARS vs WLDN Comparison
TARS vs WLDN Comparison
Compare TARS & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- WLDN
- Stock Information
- Founded
- TARS 2016
- WLDN 1964
- Country
- TARS United States
- WLDN United States
- Employees
- TARS N/A
- WLDN N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- WLDN Military/Government/Technical
- Sector
- TARS Health Care
- WLDN Consumer Discretionary
- Exchange
- TARS Nasdaq
- WLDN Nasdaq
- Market Cap
- TARS 1.7B
- WLDN 1.6B
- IPO Year
- TARS 2020
- WLDN 2006
- Fundamental
- Price
- TARS $49.36
- WLDN $100.99
- Analyst Decision
- TARS Strong Buy
- WLDN Strong Buy
- Analyst Count
- TARS 7
- WLDN 2
- Target Price
- TARS $67.14
- WLDN $111.50
- AVG Volume (30 Days)
- TARS 652.0K
- WLDN 502.4K
- Earning Date
- TARS 11-12-2025
- WLDN 10-30-2025
- Dividend Yield
- TARS N/A
- WLDN N/A
- EPS Growth
- TARS N/A
- WLDN 94.22
- EPS
- TARS N/A
- WLDN 2.39
- Revenue
- TARS $295,521,000.00
- WLDN $628,172,000.00
- Revenue This Year
- TARS $33,170.29
- WLDN N/A
- Revenue Next Year
- TARS N/A
- WLDN $9.00
- P/E Ratio
- TARS N/A
- WLDN $42.12
- Revenue Growth
- TARS 254.45
- WLDN 13.82
- 52 Week Low
- TARS $30.23
- WLDN $30.43
- 52 Week High
- TARS $59.76
- WLDN $121.00
- Technical
- Relative Strength Index (RSI)
- TARS 36.86
- WLDN 48.97
- Support Level
- TARS $55.45
- WLDN $93.80
- Resistance Level
- TARS $59.76
- WLDN $104.23
- Average True Range (ATR)
- TARS 2.01
- WLDN 4.92
- MACD
- TARS -1.34
- WLDN -2.07
- Stochastic Oscillator
- TARS 8.77
- WLDN 28.83
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About WLDN Willdan Group Inc.
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.